Back
Adaptimmune Therapeutics PLC Quote, Financials, Valuation and Earnings
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Sell
4
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.59
Seasonality Move:
50.57%
7 Day Trial
ALL ACCESS PASS
$
7
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.Adaptimmune Therapeutics PLC Price Quote
$0.59
+0.00 (+-0.2%)
(Updated: November 16, 2024 at 5:05 AM ET)
Adaptimmune Therapeutics PLC Key Stats
Sell
4
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Day range:
$0.58 - $0.61
52-week range:
$0.42 - $2.05
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.83
P/B ratio:
1.88%
Volume:
3.4M
Avg. volume:
1.6M
1-year change:
17.32%
Market cap:
$150.1M
Revenue:
$60.3M
EPS:
$-0.18
How Much Does Adaptimmune Therapeutics PLC Make?
-
How Much Are Adaptimmune Therapeutics PLC's Sales Annually?
ADAP Revenues are $60.3M -
How Much Profit Does Adaptimmune Therapeutics PLC's Make A Year?
ADAP net income is -$113.9M
Is Adaptimmune Therapeutics PLC Growing As A Company?
-
What Is Adaptimmune Therapeutics PLC's Growth Rate Quarterly?
Quarterly YoY revenue growth is 4.59% -
What Is Adaptimmune Therapeutics PLC's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Adaptimmune Therapeutics PLC Stock Price Performance
-
Did Adaptimmune Therapeutics PLC Stock Go Up Last Month?
Adaptimmune Therapeutics PLC share price went down by -33.34% last month -
Did ADAP's Share Price Rise Over The Last Year?
ADAP share price rose by 17.32% over the past 1 year
What Is Adaptimmune Therapeutics PLC 52-Week High & Low?
-
What Is Adaptimmune Therapeutics PLC’s 52-Week High Share Price?
Adaptimmune Therapeutics PLC has traded as high as $2.05 over the past 52 weeks -
What Is Adaptimmune Therapeutics PLC’s 52-Week Low Share Price?
Adaptimmune Therapeutics PLC has traded as low as $0.42 over the past 52 weeks
Adaptimmune Therapeutics PLC Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Adaptimmune Therapeutics PLC?
-
How Much Debt Does Adaptimmune Therapeutics PLC Have?
Total long term debt quarterly is $49.9M -
How Much Cash Does Adaptimmune Therapeutics PLC Have?
Cash and short term investments quarterly total is $186.1M -
What Is Adaptimmune Therapeutics PLC’s Book Value Per Share?
Book value per share is 0.31
Is Adaptimmune Therapeutics PLC Cash Flow Positive?
-
What Is ADAP Cash Flow From Operations?
Cash flow from operations (TTM) is -$53.7M -
What Is Adaptimmune Therapeutics PLC’s Cash Flow From Financing?
Cash flow from financing (TTM) is $78.8M -
What Is Adaptimmune Therapeutics PLC’s Cash Flow From Investing?
Cash flow from investing (TTM) is $1.1M
Adaptimmune Therapeutics PLC Return On Invested Capital
-
Is Management Doing A Good Job?
ADAP return on invested capital is -55.22% -
What Is Adaptimmune Therapeutics PLC Return On Assets?
ROA measures how assets are converting to revenues and is -15.08% -
What Is ADAP Return On Equity?
ROE is a measure of profitability and is -67.8%
Adaptimmune Therapeutics PLC Earnings Date & Stock Price
-
What Is Adaptimmune Therapeutics PLC's Stock Price Today?
A single share of ADAP can be purchased today for 0.59 -
What Is Adaptimmune Therapeutics PLC’s Stock Symbol?
Adaptimmune Therapeutics PLC trades on the nasdaq under the ticker symbol: ADAP -
When Is Adaptimmune Therapeutics PLC’s Next Earnings Date?
The next quarterly earnings date for Adaptimmune Therapeutics PLC is scheduled on March 6, 2025 -
When Is ADAP's next ex-dividend date?
Adaptimmune Therapeutics PLC's next ex-dividend date is November 18, 2024 -
How To Buy Adaptimmune Therapeutics PLC Stock?
You can buy Adaptimmune Therapeutics PLC shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Adaptimmune Therapeutics PLC Competitors
-
Who Are Adaptimmune Therapeutics PLC's Competitors?
Below is a list of companies who compete with Adaptimmune Therapeutics PLC or are related in some way:
Adaptimmune Therapeutics PLC Dividend Yield
-
What Is ADAP Dividend Yield?
Adaptimmune Therapeutics PLC’s dividend yield currently is 0% -
What Is Adaptimmune Therapeutics PLC’s Payout Ratio?
Adaptimmune Therapeutics PLC’s payout ratio is 0% -
When Did Adaptimmune Therapeutics PLC Last Pay A Dividend?
The latest dividend pay date is November 18, 2024 -
What Is Adaptimmune Therapeutics PLC’s Dividend Per Share?
Adaptimmune Therapeutics PLC pays a dividend of $0.00 per share
Adaptimmune Therapeutics PLC Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 94.54% |
| Revenue: | 458.83% | 99.63% |
Analyst Recommendations
| Buy Recommendations: | 4 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 2.57 |
| Upside from Last Price: | 338.5% |